Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2025-12-26 @ 4:03 PM
NCT ID:
NCT06528106
Brief Summary:
To test the implementation of penicillin allergy de-labelling delivered by the responsible clinical teams and the antimicrobial stewardship teams across all medical, surgical and critical care specialities in a UK hospital using the developed toolkit and a validated penicillin allergy decision support tool.
Detailed Description:
Aim:
To test implementation of the penicillin allergy de-labelling complex intervention in surgical, medical and critical care patient pathway.
Objectives:
* To use the Institute for Health Improvement (IHI) Model for Improvement methodology to implement the penicillin allergy de-labelling complex intervention in each setting (surgery, medicine, critical care)
* To measure the number of patients meeting inclusion criteria (\>16 with a penA not prescribed first line antibiotics) who have had their penicillin allergy record assessed by the wider clinical teams and separately by the AMS team.
* To measure the patient uptake of penicillin allergy record removal (i.e. the rate of patient declining de-label / DOC).
To interview 10-15 patients and 10-15 healthcare workers to gain insight into the penicillin allergy de labelling process.
Study:
NCT06528106
Study Brief:
Protocol Section:
NCT06528106